Tapering with Pharmaceutical GHB or Benzodiazepines for Detoxification in GHB-Dependent Patients: A Matched-Subject Observational Study of Treatment-as-Usual in Belgium and The Netherlands

BACKGROUND: The gamma-hydroxybutyric acid (GHB) withdrawal syndrome often has a fulminant course, with a rapid onset and swift progression of severe complications. In clinical practice, two pharmacological regimens are commonly used to counteract withdrawal symptoms during GHB detoxification: taperi...

Descripción completa

Detalles Bibliográficos
Autores principales: Beurmanjer, Harmen, Luykx, J. J., De Wilde, B., van Rompaey, K., Buwalda, V. J. A., De Jong, C. A. J., Dijkstra, B. A. G., Schellekens, A. F. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275016/
https://www.ncbi.nlm.nih.gov/pubmed/32319006
http://dx.doi.org/10.1007/s40263-020-00730-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275016/
https://www.ncbi.nlm.nih.gov/pubmed/32319006
http://dx.doi.org/10.1007/s40263-020-00730-8

Ejemplares similares